Compugen | CGEN - Ordinary Share Capital


Compugen reported $94.55M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Arca Biopharma USD 48.72M 338K Dec/2025
aTyr Pharma USD 16.65M 81.34M Dec/2025
Bio Path USD 9.24M 934K Sep/2025
Brainstorm Cell Therapeutics USD 11.04M 2K Dec/2025
Cara Therapeutics USD 9.38M 9.38M Sep/2025
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 94.55M 1.02M Dec/2025
Immunic USD 8K 4K Jun/2024
Infinity Pharmaceuticals USD 90K 1000 Jun/2023
Minerva Neurosciences USD 1000 0 Sep/2024
RedHill Biopharma USD 33.3B 20.4B Jun/2025
TherapeuticsMD USD 11K 0 Sep/2023